Why buying this FTSE 100 growth and income hero could help you achieve financial independence

Rupert Hargreaves looks at a FTSE 100 (INDEXFTSE: UKX) champion that could help investors make a million, but would steer clear of this FTSE 250 (INDEXFTSE:MCX) firm.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

At the beginning of this year, my Foolish colleague Roland Head picked out defence group Chemring  (LSE: CHG) as one of his favourite dividend growth stocks. Citing the firm’s 131% dividend hike from 1.3p to 3p, Roland claimed that the company’s turnaround was starting to pay off, and over the next few years, investors should be rewarded with growth. 

As it turns out, this forecast was accurate. Since the beginning of 2018, as market sentiment towards the group has improved, shares in Chemring have added 31% excluding dividends, outpacing the FTSE 250 by 30%.

Inflation Is Coming

Inflation is out of control, and people are running scared. But right now there’s one thing we believe Investors should avoid doing at all costs… and that’s doing nothing. That’s why we’ve put together a special report that uncovers 3 of our top UK and US share ideas to try and best hedge against inflation… and better still, we’re giving it away completely FREE today!

Click here to claim your copy now!

However, I believe the shares will struggle to replicate this performance during the second half of the year. 

Unforeseen disaster

After rising by more than a third during the first half of 2018, shares in Chemring were trading at a premium earnings multiple at the end of last week. Even though the City was expecting a 12% decline in EPS for the full year, shares in Chemring were still trading at a forward P/E of 18. 

Unfortunately, on Friday evening, an incident occurred in a flare manufacturing building at the Chemring Countermeasures facility, near Salisbury, which resulted in the death of one employee and hospitalised another. Following this event, the facility is now out of action and management is, at this stage, unable to forecast how it will impact results. Previously, it was expected that Chemring Countermeasures would contribute £15m to group 2018 underlying operating profit. According to management, operating profit is “now likely to be approximately £10m-£20m lower than previous expectations.” City analysts had been expecting a net profit of £37m for the year ending October 2018. 

This tragic accident is another setback for a company that has struggled to remain profitable for the last six years. Since 2012, Chemring has only generated £47m of operating profit, on total revenues of £3bn, giving an average operating margin of just 2%. Based on these figures, and the group’s relatively high valuation, I’d avoid the stock. 

One company that has a better record of producing returns for investors is FTSE 100 leader Croda (LSE: CRDA)

A price worth paying 

Croda has gone from strength to strength over the past five years. The speciality chemicals group has seen demand for products surge as the world grows. It manufactures everything from cosmetic products to industrial lubricants, products for the healthcare industry and agriculture business. Over the past five years, as revenues have increased 30%, net profit has surged 57%. Since mid-2013, excluding dividends, the stock has doubled. 

I expect this trend to continue. Even though shares in Croda trade at a hefty 26 times forward earnings, I believe this is a multiple worth paying. Croda is what I would call a wide moat business. The production of chemicals is a highly specialised business with high barriers to entry. It’s not easy to just set up and start producing fertilisers for example. There are whole books of rules and regulations to follow. Croda also has established relationships with customers, who know and trust the group. 

With this being the case, I believe the firm can continue to achieve market-beating growth, and it’s worth paying a high multiple to get your hands on the shares. 

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Rupert Hargreaves does not own any share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Should you invest the value of your investment may rise or fall and your Capital is at Risk. Before investing your individual circumstances should be considered, so you should consider taking independent financial advice.

More on Investing Articles

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

How I’d apply the Warren Buffett method to buying shares

Learning from billionaire investor Warren Buffett, our writer explains his own approach to investing in shares for his portfolio.

Read more »

pensive bearded business man sitting on chair looking out of the window
Investing Articles

This dividend share yields under 1% — but I’d still buy it

This dividend share has a low yield. So why would our writer consider adding it to his income portfolio?

Read more »

Young lady working from home office during coronavirus pandemic.
Investing Articles

Looking for a good share to buy? Here’s how I do it

Here are two approaches our writer uses when hunting for a good share to buy for his portfolio to aim…

Read more »

man in shirt using computer and smiling while working in the office
Investing Articles

One cheap FTSE 100 share I’d buy for a new bull market

This FTSE 100 share is unloved and starting to look seriously cheap, says Roland Head.

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

How I’d invest £500 in UK shares in 2022

Investing a small amount of capital in UK shares can result in high commission costs. Zaven Boyrazian explains how to…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

2 battered FTSE dividend stocks to buy in July!

I'm still searching the FTSE 100 for the best bargains to buy. I think these two big dividend shares are…

Read more »

Woman pulling baffled face
Investing Articles

Can I trust Lloyds’ 6.1% dividend yield?

The Lloyds' share price has sunk in 2022, causing the bank's dividend yield to leap. But can I really trust…

Read more »

Young mixed-race woman looking out of the window with a look of consternation on her face
Investing Articles

3 top stocks to buy before the market rebounds

Edward Sheldon highlights three beaten-up stocks he'd buy before global stock markets stage a recovery from their 2022 declines.

Read more »